Status:
UNKNOWN
The Role of Lumbar Multifidus Characteristics in the Development of Low Back Pain
Lead Sponsor:
The Hong Kong Polytechnic University
Collaborating Sponsors:
University of Oulu
The University of Hong Kong
Conditions:
Low Back Pain
Eligibility:
All Genders
18-65 years
Brief Summary
Low back pain (LBP) is a severe epidemic in the world. Despite its high prevalence, 90% of the cases have no identifiable cause. Approximately 44% of them experience recurrent LBP within one year and ...
Detailed Description
Low back pain (LBP) is a severe epidemic in the world. Despite its high prevalence, 90% of the cases have no identifiable cause. While most people with LBP recover shortly after onset, approximately 4...
Eligibility Criteria
Inclusion
- aged 18 to 65 years
- Symptomatic participants should have LBP that requires medical consultation(s) in the last three months
- LBP intensity of at least 5 on the 11-point numeric pain rating scale at baseline (for symptomatic participants)
- Asymptomatic participants should be pain free at baseline, and should not have LBP in the last year nor LBP lasting more than a week in the last 3 years
Exclusion
- a history of neurological disease or vestibular impairment
- systemic inflammatory disease
- prior spinal surgery
- acute/chronic neuropathy or radiculopathy
- spinal infections/fractures/tumors, metabolic disorders,
- medical 'red flags'
Key Trial Info
Start Date :
August 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2022
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT03387930
Start Date
August 1 2017
End Date
June 30 2022
Last Update
February 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Queen Mary Hospital
Hong Kong, Hong Kong